Lilly Diabetes is ending its partnership with Roush Fenway Racing at the end of the season, the company announced Monday.
Since 2013 when Ryan Reed made his first Xfinity Series starts, Lilly has served as the primary sponsor on his No. 16 Ford. The company is also the “Official Diabetes Health Partner of NASCAR.”
“For the past five years, we have been fortunate to have had a wonderful partnership with Ryan Reed and Roush Fenway Racing. Together, we have increased awareness among NASCAR fans about the importance of managing diabetes and have inspired people with diabetes to live the lives they want to live,” the company said in a statement announcing its decision. “Moving forward, we have decided to shift our focus to other initiatives that support the diabetes community and, therefore, our partnership with Roush Fenway Racing to sponsor Ryan will end at the conclusion of the 2018 NASCAR season.
“We are grateful to Ryan for his dedication to the diabetes community, and we admire all he has accomplished. We wish him all the success in the future as we turn from sponsor to fans. We also thank Jack Roush and the team at Roush Fenway Racing for their exceptional partnership. As the Official Diabetes Health Partner of NASCAR, we look forward to continuing our support of fans impacted by diabetes through our educational initiatives that raise awareness of the importance of diabetes management and overall good health.”
Reed posted a statement of his own on Twitter thanking Lilly for its support amid his uncertain future:
A two-time winner in the series, both at Daytona in Feb. 2015 and ’17, Reed has qualified for the playoffs in each of the last three seasons and finished a career-best sixth in points in 2016. Reed also made his NASCAR Cup Series debut at Talladega in the fall of ’16.